4//SEC Filing
DiBiase Mary 4
Accession 0001628280-25-005696
CIK 0001501697other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:08 PM ET
Size
5.3 KB
Accession
0001628280-25-005696
Insider Transaction Report
Form 4
DiBiase Mary
Chief Operating Officer
Transactions
- Award
Common Stock
2025-02-12+650,000→ 1,140,980 total
Footnotes (1)
- [F1]Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on February 12, 2026, February 12, 2027 and February 12, 2028, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001880179
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:08 PM ET
- Size
- 5.3 KB